
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
C–H functionalisation tolerant to polar groups could transform fragment-based drug discovery (FBDD)
Gianni Chessari, Rachel Grainger, Rhian S. Holvey, et al.
Chemical Science (2021) Vol. 12, Iss. 36, pp. 11976-11985
Open Access | Times Cited: 31
Gianni Chessari, Rachel Grainger, Rhian S. Holvey, et al.
Chemical Science (2021) Vol. 12, Iss. 36, pp. 11976-11985
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Accelerated Chemical Reaction Optimization Using Multi-Task Learning
Connor J. Taylor, Kobi Felton, Daniel Wigh, et al.
ACS Central Science (2023) Vol. 9, Iss. 5, pp. 957-968
Open Access | Times Cited: 62
Connor J. Taylor, Kobi Felton, Daniel Wigh, et al.
ACS Central Science (2023) Vol. 9, Iss. 5, pp. 957-968
Open Access | Times Cited: 62
Fragment-to-Lead Medicinal Chemistry Publications in 2020
Iwan J. P. de Esch, Daniel A. Erlanson, Wolfgang Jahnke, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 1, pp. 84-99
Open Access | Times Cited: 81
Iwan J. P. de Esch, Daniel A. Erlanson, Wolfgang Jahnke, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 1, pp. 84-99
Open Access | Times Cited: 81
Fragment-to-Lead Medicinal Chemistry Publications in 2021
Louise Walsh, Daniel A. Erlanson, Iwan J. P. de Esch, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 2, pp. 1137-1156
Open Access | Times Cited: 34
Louise Walsh, Daniel A. Erlanson, Iwan J. P. de Esch, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 2, pp. 1137-1156
Open Access | Times Cited: 34
Fragment-to-Lead Medicinal Chemistry Publications in 2023
Rhian S. Holvey, Daniel A. Erlanson, Iwan J. P. de Esch, et al.
Journal of Medicinal Chemistry (2025) Vol. 68, Iss. 2, pp. 986-1001
Closed Access | Times Cited: 1
Rhian S. Holvey, Daniel A. Erlanson, Iwan J. P. de Esch, et al.
Journal of Medicinal Chemistry (2025) Vol. 68, Iss. 2, pp. 986-1001
Closed Access | Times Cited: 1
Escape from planarity in fragment-based drug discovery: A synthetic strategy analysis of synthetic 3D fragment libraries
Hanna F. Klein, David J. Hamilton, Iwan J. P. de Esch, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 9, pp. 2484-2496
Open Access | Times Cited: 32
Hanna F. Klein, David J. Hamilton, Iwan J. P. de Esch, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 9, pp. 2484-2496
Open Access | Times Cited: 32
Merging Directed C–H Activations with High-Throughput Experimentation: Development of Iridium-Catalyzed C–H Aminations Applicable to Late-Stage Functionalization
Erik Weis, Maria C. Johansson, Pernilla Korsgren, et al.
JACS Au (2022) Vol. 2, Iss. 4, pp. 906-916
Open Access | Times Cited: 27
Erik Weis, Maria C. Johansson, Pernilla Korsgren, et al.
JACS Au (2022) Vol. 2, Iss. 4, pp. 906-916
Open Access | Times Cited: 27
Fragment Libraries Designed to Be Functionally Diverse Recover Protein Binding Information More Efficiently Than Standard Structurally Diverse Libraries
Anna Carbery, R. Skyner, F. von Delft, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 16, pp. 11404-11413
Open Access | Times Cited: 27
Anna Carbery, R. Skyner, F. von Delft, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 16, pp. 11404-11413
Open Access | Times Cited: 27
Analyzing Oxygen Atom Distribution in FDA‐Approved Drugs to Enhance Drug Discovery Strategies
Vijay H. Masand, Meghshyam K. Patil, Sami A. Al‐Hussain, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 2
Closed Access
Vijay H. Masand, Meghshyam K. Patil, Sami A. Al‐Hussain, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 2
Closed Access
Enabling synthesis in fragment-based drug discovery (FBDD): microscale high-throughput optimisation of the medicinal chemist's toolbox reactions
Chloe Townley, Davide Branduardi, Gianni Chessari, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 12, pp. 2699-2713
Closed Access | Times Cited: 8
Chloe Townley, Davide Branduardi, Gianni Chessari, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 12, pp. 2699-2713
Closed Access | Times Cited: 8
Discovery of potent SARS-CoV-2 nsp3 macrodomain inhibitors uncovers lack of translation to cellular antiviral response
Alpha A. Lee, Isabelle Amick, Jasmin C. Aschenbrenner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Alpha A. Lee, Isabelle Amick, Jasmin C. Aschenbrenner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
On the Mechanism and Selectivity of Palladium-Catalyzed C(sp3)–H Arylation of Pyrrolidines and Piperidines at Unactivated C4 Positions: Discovery of an Improved Dimethylaminoquinoline Amide Directing Group
Daniele Antermite, Andrew J. P. White, Luis Casarrubios, et al.
ACS Catalysis (2023) Vol. 13, Iss. 14, pp. 9597-9615
Open Access | Times Cited: 6
Daniele Antermite, Andrew J. P. White, Luis Casarrubios, et al.
ACS Catalysis (2023) Vol. 13, Iss. 14, pp. 9597-9615
Open Access | Times Cited: 6
Puckering the Planar Landscape of Fragments: Design and Synthesis of a 3D Cyclobutane Fragment Library
David J. Hamilton, Marieke Beemsterboer, Caroline M. Carter, et al.
ChemMedChem (2022) Vol. 17, Iss. 9
Open Access | Times Cited: 8
David J. Hamilton, Marieke Beemsterboer, Caroline M. Carter, et al.
ChemMedChem (2022) Vol. 17, Iss. 9
Open Access | Times Cited: 8
Green Drug Discovery: Novel Fragment Space from the Biomass-Derived Molecule Dihydrolevoglucosenone (CyreneTM)
Tom Dekker, Jaap W. Harteveld, Gábor Wágner, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1777-1777
Open Access | Times Cited: 4
Tom Dekker, Jaap W. Harteveld, Gábor Wágner, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1777-1777
Open Access | Times Cited: 4
Identification of BACE-1 inhibitors through directed C(sp3)-H activation on 5-oxo-pyrrolidine-3-carboxylic acid derivatives
Lorenzo Baldini, Elena Lenci, Cristina Faggi, et al.
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 14, pp. 2754-2763
Open Access | Times Cited: 1
Lorenzo Baldini, Elena Lenci, Cristina Faggi, et al.
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 14, pp. 2754-2763
Open Access | Times Cited: 1
The Power of High-Throughput Experimentation: Case Studies from Drug Discovery, Drug Development, and Catalyst Discovery (Volume 2)
ACS symposium series (2022)
Closed Access | Times Cited: 6
ACS symposium series (2022)
Closed Access | Times Cited: 6
Synthesis of sp3-rich heterocyclic frameworks by a divergent synthesis strategy
Kim T. Mortensen, Denedy S. Y. Wong, Thomas A. King, et al.
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 22, pp. 4591-4595
Open Access | Times Cited: 2
Kim T. Mortensen, Denedy S. Y. Wong, Thomas A. King, et al.
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 22, pp. 4591-4595
Open Access | Times Cited: 2
Synthesis and vectorial functionalisation of pyrazolo[3,4-c]pyridines
Elizabeth V. Bedwell, Flávio da Silva Emery, Giuliano C. Clososki, et al.
RSC Advances (2023) Vol. 13, Iss. 49, pp. 34391-34399
Open Access | Times Cited: 2
Elizabeth V. Bedwell, Flávio da Silva Emery, Giuliano C. Clososki, et al.
RSC Advances (2023) Vol. 13, Iss. 49, pp. 34391-34399
Open Access | Times Cited: 2
HTE as a Tool in C–H Activation Reaction Discovery and Late-Stage Functionalization of Pharmaceuticals
Stig D. Friis, Erik Weis, Magnus J. Johansson
ACS symposium series (2022), pp. 161-179
Closed Access | Times Cited: 3
Stig D. Friis, Erik Weis, Magnus J. Johansson
ACS symposium series (2022), pp. 161-179
Closed Access | Times Cited: 3
Directed Arylation of 7‐Oxabicyclo[2.2.1]heptane to Prepare 3D Fragments
Max J. Caplin, Imogen M. Alderson, Daniel J. Foley
European Journal of Organic Chemistry (2024)
Open Access
Max J. Caplin, Imogen M. Alderson, Daniel J. Foley
European Journal of Organic Chemistry (2024)
Open Access
A review of the known MTA-cooperative PRMT5 inhibitors
Mei Hu, Xiang Chen
RSC Advances (2024) Vol. 14, Iss. 53, pp. 39653-39691
Open Access
Mei Hu, Xiang Chen
RSC Advances (2024) Vol. 14, Iss. 53, pp. 39653-39691
Open Access
Back in Person: Frontiers in Medicinal Chemistry 2023
Matthias Gehringer, Felix Pape, Marı́a Méndez, et al.
ChemMedChem (2023) Vol. 18, Iss. 19
Open Access | Times Cited: 1
Matthias Gehringer, Felix Pape, Marı́a Méndez, et al.
ChemMedChem (2023) Vol. 18, Iss. 19
Open Access | Times Cited: 1
Lead Generation
Frank Narjes, Garry Pairaudeau, Dušan Petrović
The Royal Society of Chemistry eBooks (2023), pp. 682-719
Closed Access | Times Cited: 1
Frank Narjes, Garry Pairaudeau, Dušan Petrović
The Royal Society of Chemistry eBooks (2023), pp. 682-719
Closed Access | Times Cited: 1
High-Throughput Experimentation for Medicinal Chemistry: State of the Art, Challenges, and Opportunities
Dipannita Kalyani, Mycah R. Uehling, Michael Wleklinski
ACS symposium series (2022), pp. 37-66
Closed Access | Times Cited: 2
Dipannita Kalyani, Mycah R. Uehling, Michael Wleklinski
ACS symposium series (2022), pp. 37-66
Closed Access | Times Cited: 2
Leveraging HTE in Non-canonical Amino Acid Synthesis and Peptide Ligation
Niki R. Patel, Danielle M. Schultz
ACS symposium series (2022), pp. 109-120
Closed Access | Times Cited: 1
Niki R. Patel, Danielle M. Schultz
ACS symposium series (2022), pp. 109-120
Closed Access | Times Cited: 1
Accelerated Chemical Reaction Optimization using Multi-Task Learning
Connor J. Taylor, Kobi Felton, Daniel Wigh, et al.
(2023)
Open Access
Connor J. Taylor, Kobi Felton, Daniel Wigh, et al.
(2023)
Open Access